PHPMem v2.0.1
Version
1.6.45
Uptime
15 days 8 hours 18 minutes 51 seconds
Memory
Total
512MB
Used
24,01MB (4.69%)
Free
487,99MB
Keys
Current
27 650
Total (since start)
33 978
Evictions
0
Reclaimed
160
Expired Unfetched
0
Evicted Unfetched
0
Connections
Current
11 / 1 024 max
Total
170 052
Rejected
0
llm:41794a85c3835241a3973951e0906e4f2e2af7cf3fde51706017a83b9392d4c4
Edit
```json
{
"slots": [
{
"scope": "dataset",
"slot": "nature",
"value": {
"nature": "operational"
},
"evidence": {
"reasoning": "This dataset records adverse events (AE) occurring during a clinical trial (CDISCPILOT01). These events are produced by running a controlled clinical study process, with structured data capture of patient experiences, event classifications, severity assessments, and outcomes. The presence of study identifiers, sequence numbers, relationship-to-treatment assessments (AEREL), and action taken fields (AEACN) indicates this is operational trial data generated through protocol execution."
}
},
{
"scope": "dataset",
"slot": "decisions_served",
"value": {
"decisions": [
"Whether to halt or modify the clinical trial based on adverse event patterns",
"Whether an individual adverse event requires immediate medical intervention or hospitalization",
"Whether to adjust dosing or discontinue treatment for specific patients experiencing adverse events",
"Whether to report serious adverse events to regulatory authorities",
"Whether adverse event profiles support drug safety for regulatory approval"
]
},
"evidence": {
"reasoning": "The table captures severity (AESEV), seriousness flags (AESER), outcomes (AEOUT), and specific serious event indicators (death, hospitalization, disability, life-threatening). These fields directly support safety monitoring decisions. The relationship-to-treatment field (AEREL) enables causality assessment. The temporal data (start/end dates) allows tracking event progression for intervention decisions."
}
},
{
"scope": "dataset",
"slot": "levers",
"value": {
"levers": [
"Discontinue or modify study drug administration for affected patients",
"Implement additional safety monitoring protocols",
"Adjust patient enrollment criteria to exclude high-risk populations",
"Modify study protocol based on emerging safety signals"
]
},
"evidence": {
"reasoning": "Clinical trial operators control drug administration, protocol modifications, and enrollment decisions. The AEACN (action taken) field, though currently missing values, is designed to capture actions taken in response to adverse events. Operators can pull levers like dose adjustment, treatment discontinuation, or protocol amendments based on this safety data."
}
},
{
"scope": "dataset",
"slot": "audience",
"value": {
"audience": [
"Clinical trial safety monitors",
"Principal investigators and site physicians",
"Regulatory affairs specialists",
"Data safety monitoring boards",
"Clinical research associates",
"Pharmacovigilance teams"
]
},
"evidence": {
"reasoning": "The structured adverse event coding (MedDRA hierarchy: SOC, HLGT, HLT, LLT), seriousness criteria, and relationship assessments are standard elements used by safety professionals. The data supports both real-time safety monitoring during the trial and regulatory reporting requirements."
}
},
{
"scope": "table:ae",
"slot": "role",
"value": {
"role": "fact"
},
"evidence": {
"reasoning": "The derived role of 'fact' is correct. This table records individual adverse event occurrences (facts) at the patient-event level, with composite key USUBJID+AESEQ. Each row represents a distinct adverse event instance with measurements of severity, outcome, and temporal attributes."
}
},
{
"scope": "table:ae",
"slot": "grain",
"value": {
"unit": "one row per adverse event occurrence per patient",
"key_columns": ["USUBJID", "AESEQ"]
},
"evidence": {
"reasoning": "The composite primary key (USUBJID, AESEQ) defines the grain. USUBJID identifies the patient (225 unique subjects), and AESEQ is the sequence number for multiple events per patient (monotonicity 0.56 indicates ordering). With 1191 rows across 225 patients, multiple adverse events per patient are captured sequentially."
}
},
{
"scope": "table:ae",
"slot": "temporal_posture",
"value": {
"posture": "interval",
"columns": ["AESTDTC", "AEENDTC", "AEDTC"]
},
"evidence": {
"reasoning": "Adverse events have start dates (AESTDTC), end dates (AEENDTC), and report dates (AEDTC). The posture is 'interval' rather than 'typed' because events span time periods with defined beginnings and endings. AESTDY and AEENDY represent study days relative to treatment start, reinforcing the interval nature. Some events remain unresolved (AEENDTC missing), indicating ongoing intervals."
}
},
{
"scope": "table:ae",
"slot": "column_bindings",
"value": {
"bindings": [
{"column": "STUDYID", "binding": "identifier"},
{"column": "DOMAIN", "binding": "category"},
{"column": "USUBJID", "binding": "identifier"},
{"column": "AESEQ", "binding": "identifier"},
{"column": "AESPID", "binding": "identifier"},
{"column": "AETERM", "binding": "category"},
{"column": "AELLT", "binding": "category"},
{"column": "AEDECOD", "binding": "category"},
{"column": "AEHLT", "binding": "category"},
{"column": "AEHLGT", "binding": "category"},
{"column": "AEBODSYS", "binding": "category"},
{"column": "AESOC", "binding": "category"},
{"column": "AESEV", "binding": "category"},
{"column": "AESER", "binding": "flag"},
{"column": "AEREL", "binding": "category"},
{"column": "AEOUT", "binding": "category"},
{"column": "AESCAN", "binding": "flag"},
{"column": "AESCONG", "binding": "flag"},
{"column": "AESDISAB", "binding": "flag"},
{"column": "AESDTH", "binding": "flag"},
{"column": "AESHOSP", "binding": "flag"},
{"column": "AESLIFE", "binding": "flag"},
{"column": "AESOD", "binding": "flag"},
{"column": "AEDTC", "binding": "temporal"},
{"column": "AESTDTC", "binding": "temporal"},
{"column": "AEENDTC", "binding": "temporal"},
{"column": "AESTDY", "binding": "measure"},
{"column": "AEENDY", "binding": "measure"}
]
},
"evidence": {
"reasoning": "Refining the derived bindings: AESER, AESCAN, AESCONG, AESDISAB, AESDTH, AESHOSP, AESLIFE, AESOD are Y/N flags indicating boolean conditions (serious, scan required, congenital, disability, death, hospitalization, life-threatening, significant overdose) and should be 'flag' not 'category'. AESTDY and AEENDY are numeric study day offsets (measures) not categories. The MedDRA hierarchy columns (AELLT, AEDECOD, AEHLT, AEHLGT, AEBODSYS, AESOC) and AETERM are categorical classifications. Code columns (AELLTCD, AEPTCD, etc.) are omitted as they contain only missing values."
}
}
]
}
```